Mwandishi:
ULY CLINIC
Mhariri:
ULY CLINIC
Imeboreshwa:
2 Machi 2026, 02:55:12
Aphthous ulceration
Aphthous ulceration, also known as Recurrent Aphthous Stomatitis (RAS), is a common inflammatory condition characterized by recurrent, painful ulcerations affecting the non-keratinized oral mucosa without association with systemic infection.
It represents the most common ulcerative disease of the oral cavity, affecting approximately 10–25% of the general population. Lesions typically recur at variable intervals and significantly impair eating, swallowing, speech, and oral hygiene.
Commonly affected sites include:
Labial mucosa
Buccal mucosa
Ventral surface of tongue
Floor of mouth
Soft palate
Keratinized tissues such as gingiva and hard palate are usually spared.
Pathophysiology
The exact etiology remains multifactorial and incompletely understood. Current evidence supports an immune-mediated mucosal destruction process.
Major mechanisms involved:
1. Immune Dysregulation
Cell-mediated immune response predominates
Increased T-lymphocyte activation
Cytotoxic CD8+ cells destroy epithelial cells
Elevated pro-inflammatory cytokines:
TNF-α
Interleukin-2
Interferon-γ
This leads to epithelial breakdown and ulcer formation.
2. Predisposing Factors
RAS occurs in genetically susceptible individuals exposed to triggering factors:
Local factors
Minor oral trauma
Tooth brushing injury
Dental procedures
Sharp tooth margins or prosthesis
Systemic factors
Iron deficiency anemia
Vitamin B12 deficiency
Folate deficiency
Zinc deficiency
Hormonal fluctuations
Psychological stress
Food hypersensitivity
Associated systemic diseases
Behçet disease
Celiac disease
Inflammatory bowel disease
HIV infection
Neutropenia
Signs and Symptoms
Prodromal Stage
Occurs 24–48 hours before ulcer formation:
Burning sensation
Tingling
Localized itching
Mucosal tenderness
Ulcerative Stage
Round or oval ulcer
Yellow-gray fibrinous base
Surrounded by erythematous halo
Severe localized pain
Difficulty eating acidic or spicy foods
Pain during speech or swallowing
Diagnostic Criteria
Diagnosis is mainly clinical.
Classification
1. Minor Aphthous Ulcers (Mikulicz type)
Size: 2–4 mm
Number: 1–6 ulcers
Located on non-keratinized mucosa
Heal within 7–10 days
No scarring
Most common (~80%)
2. Major Aphthous Ulcers (Sutton disease)
Size: 1–3 cm
Deep painful ulcers
Significant tissue destruction
Healing: weeks to months
Often heal with scarring
May interfere with nutrition
3. Herpetiform Aphthous Ulcers
Multiple clustered ulcers (10–100 lesions)
Size: 1–5 mm
May coalesce
Heal within 7–10 days
Not related to herpes virus infection
Differential Diagnosis
Important conditions to exclude:
Oral herpes simplex infection
Oral candidiasis
Traumatic ulcer
Oral lichen planus
Pemphigus vulgaris
Squamous cell carcinoma
Drug-induced ulceration
Tuberculous ulcer
HIV-related ulcers
Investigations
Usually not required in typical recurrent cases.
Indications for investigation:
Severe or persistent ulcers
Onset in adulthood
Non-healing >3 weeks
Systemic symptoms
Recommended tests
Full blood count
Serum ferritin
Vitamin B12 level
Folate level
HIV testing (when indicated)
ESR/CRP
Biopsy for suspicious lesions
Treatment
Treatment Goals
Pain reduction
Accelerate healing
Reduce recurrence
Maintain nutrition and oral intake
Non-Pharmacological Management
Avoid spicy, acidic, or rough foods
Maintain optimal oral hygiene
Use soft toothbrush
Eliminate traumatic dental factors
Stress reduction strategies
Correct nutritional deficiencies
Adequate hydration
Protective agents:
Warm saline mouth rinse
Sodium bicarbonate mouth rinse
Protective oral pastes
Pharmacological Treatment
(Aligned with Tanzania STG & NEMLIT recommendations)
Topical Therapy (First Line)
Triamcinolone acetonide 0.1% oral paste
Apply directly to ulcer
12 hourly for 5–7 days
OR
Chlorhexidine gluconate 0.2% mouthwash
Rinse 8 hourly for 5–7 days
Reduces secondary infection
Analgesics
Paracetamol 1 g PO every 8 hours when required
Avoid NSAIDs if ulcer worsens.
Systemic Therapy (Severe Disease)
Prednisolone oral regimen:
20 mg PO 8 hourly × 3 days
Then 10 mg 8 hourly × 2 days
Then 5 mg 8 hourly × 2 days
Used only in severe or major aphthous ulceration.
Adjunct Therapies (Specialist Level)
Topical lidocaine viscous gel
Tetracycline mouth rinse
Colchicine
Dapsone
Thalidomide (specialist supervision only)
Referral Criteria
Refer to dental/oral medicine specialist if:
Ulcer persists >3 weeks
Recurrent severe disease
Suspicion of malignancy
Systemic illness suspected
Weight loss or dysphagia present
Immunocompromised patient
Biopsy may be required for histopathological diagnosis.
Prevention
Maintain oral hygiene
Avoid mucosal trauma
Nutritional supplementation when deficient
Stress management
Regular dental review
Early treatment during prodromal phase
Patients with frequent recurrence benefit from trigger identification.
Complications
Dehydration
Malnutrition
Secondary infection
Chronic pain
Reduced quality of life
References
Ministry of Health, Community Development, Gender, Elderly and Children (MoHCDGEC). Standard Treatment Guidelines and National Essential Medicines List for Tanzania Mainland (STG & NEMLIT). 6th ed. Dodoma: MoHCDGEC; 2021.
Porter SR, Scully C. Aphthous ulcers (recurrent). Clin Evid. 2005;13:1687-94.
Scully C, Felix DH. Oral medicine — Update for the dental practitioner: Aphthous and other common ulcers. Br Dent J. 2005;199(5):259-64.
Neville BW, Damm DD, Allen CM, Chi AC. Oral and Maxillofacial Pathology. 5th ed. St Louis: Elsevier; 2024.
Greenberg MS, Glick M, Ship JA. Burket’s Oral Medicine. 13th ed. Shelton (CT): PMPH-USA; 2021.
Edgar NR, Saleh D, Miller RA. Recurrent aphthous stomatitis: a review. J Clin Aesthet Dermatol. 2017;10(3):26-36.
Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent Clin North Am. 2014;58(2):281-97.
World Health Organization. Oral Health Surveys: Basic Methods. 5th ed. Geneva: WHO; 2013.
Preeti L, Magesh KT, Rajkumar K, Karthik R. Recurrent aphthous stomatitis. J Oral Maxillofac Pathol. 2011;15(3):252-6.
Arduino PG, Porter SR. Oral and perioral manifestations of systemic disease. Br Dent J. 2008;204(6):305-14.
Imeandikwa:
4 Novemba 2020, 09:11:15
